Creo Medical Group PLC
LSE:CREO
Income Statement
Earnings Waterfall
Creo Medical Group PLC
Revenue
|
29.2m
GBP
|
Cost of Revenue
|
-15.2m
GBP
|
Gross Profit
|
14.1m
GBP
|
Operating Expenses
|
-42.3m
GBP
|
Operating Income
|
-28.2m
GBP
|
Other Expenses
|
3.1m
GBP
|
Net Income
|
-25.1m
GBP
|
Income Statement
Creo Medical Group PLC
Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
+75%
|
0
-39%
|
9
+115 592%
|
22
+137%
|
0
N/A
|
25
N/A
|
26
+3%
|
27
+5%
|
29
+8%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
0
|
0
|
(0)
|
(0)
|
(0)
|
(5)
|
(12)
|
(16)
|
(14)
|
(17)
|
(14)
|
(15)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
+7%
|
0
-74%
|
4
+312 691%
|
10
+152%
|
0
N/A
|
12
N/A
|
12
+4%
|
13
+9%
|
14
+7%
|
|
Operating Income | |||||||||||||
Operating Expenses |
(10)
|
(18)
|
(17)
|
(19)
|
(20)
|
(28)
|
(34)
|
(46)
|
(41)
|
(59)
|
(44)
|
(42)
|
|
Selling, General & Administrative |
(11)
|
(18)
|
(17)
|
(19)
|
(20)
|
(28)
|
(34)
|
(46)
|
(42)
|
(59)
|
(44)
|
(42)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
|
Operating Income |
(10)
N/A
|
(18)
-72%
|
(17)
+5%
|
(19)
-12%
|
(20)
-6%
|
(23)
-17%
|
(24)
-2%
|
(33)
-39%
|
(30)
+10%
|
(44)
-48%
|
(31)
+30%
|
(28)
+8%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
Pre-Tax Income |
(10)
N/A
|
(18)
-71%
|
(17)
+6%
|
(19)
-12%
|
(20)
-6%
|
(23)
-18%
|
(24)
-4%
|
(34)
-39%
|
(30)
+10%
|
(44)
-46%
|
(31)
+30%
|
(28)
+9%
|
|
Net Income | |||||||||||||
Tax Provision |
2
|
3
|
2
|
3
|
3
|
3
|
3
|
0
|
6
|
7
|
4
|
3
|
|
Income from Continuing Operations |
(8)
|
(15)
|
(14)
|
(16)
|
(17)
|
(20)
|
(21)
|
0
|
(25)
|
(28)
|
(27)
|
(25)
|
|
Net Income (Common) |
(8)
N/A
|
(15)
-76%
|
(14)
+4%
|
(16)
-12%
|
(17)
-8%
|
(20)
-19%
|
(21)
-4%
|
0
N/A
|
(25)
N/A
|
(28)
-14%
|
(27)
+4%
|
(25)
+7%
|
|
EPS (Diluted) |
-0.1
N/A
|
-0.16
-60%
|
-0.12
+25%
|
-0.13
-8%
|
-0.12
+8%
|
-0.13
-8%
|
-0.13
N/A
|
0
N/A
|
-0.14
N/A
|
-0.15
-7%
|
-0.14
+7%
|
-0.09
+36%
|